Following submissions from both sides, Mohali chief judicial magistrate Megha Dhaliwal dismissed the VB’s application for ...

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

The discovery opens a path to the sustainable synthesis of anti-inflammatory and anti-tumor agents. Scientists at UBC Okanagan have revealed how plants create mitraphylline, a rare natural substance ...

The company believes the Food and Drug Administration may deal a setback to one of its investigational therapies.

Medical technology, the pharmaceutical industry and biotechnology are sectors in which sensors and measurement technology are increasingly being used to improve quality and efficiency. Micro-Epsilon ...

UniQure NV's stock plummeted over 54% after the FDA deemed the clinical data for its Huntington's disease gene therapy ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game-changer. | FDA is said to be making a U-turn on ...

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and provides ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

An expanded soybean portfolio, new herbicide formulation and a new trait on the near horizon are flowing through the pipeline ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug ...